We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.72B
AUM Growth
+$377M
Cap. Flow
-$47.5M
Cap. Flow %
-0.83%
Top 10 Hldgs %
18.31%
Holding
1,615
New
130
Increased
604
Reduced
665
Closed
130

Sector Composition

Rank Sector Weight
1 Technology 19.17%
2 Financials 10.88%
3 Healthcare 10.31%
4 Consumer Discretionary 9.37%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PII icon
1251
Polaris
PII
$3.88B
$284K 0.01%
2,583
+228
+10% +$26.9K
HIG icon
1252
Hartford Financial Services
HIG
$39.2B
$283K ﹤0.01%
4,095
+704
+21% +$49.7K
PIZ icon
1253
Invesco Dorsey Wright Developed Markets Momentum ETF
PIZ
$719M
$283K ﹤0.01%
7,019
-32
-0.5% -$1.26K
SLYG icon
1254
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.08B
$283K ﹤0.01%
+3,048
New +$278K
AEE icon
1255
Ameren
AEE
$30.1B
$282K ﹤0.01%
3,167
-4,405
-58% -$374K
BME icon
1256
BlackRock Health Sciences Trust
BME
$563M
$282K ﹤0.01%
5,816
-290
-5% -$13.7K
DOCN icon
1257
DigitalOcean
DOCN
$14.1B
$282K ﹤0.01%
+3,511
New +$329K
PEJ icon
1258
Invesco Leisure and Entertainment ETF
PEJ
$260M
$282K ﹤0.01%
5,762
+682
+13% +$33.9K
AFT
1259
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$280K ﹤0.01%
17,398
+128
+0.7% +$2.06K
DLTR icon
1260
Dollar Tree
DLTR
$24.7B
$279K ﹤0.01%
1,983
-15,918
-89% -$1.93M
PCN
1261
PIMCO Corporate & Income Strategy Fund
PCN
$873M
$277K ﹤0.01%
16,169
+90
+0.6% +$1.62K
LMND icon
1262
Lemonade
LMND
$3.76B
$276K ﹤0.01%
6,550
-768
-10% -$43.2K
AON icon
1263
Aon
AON
$77.8B
$275K ﹤0.01%
916
+35
+4% +$10.5K
IYF icon
1264
iShares US Financials ETF
IYF
$4.67B
$275K ﹤0.01%
3,168
WRAP icon
1265
Wrap Technologies
WRAP
$98.1M
$275K ﹤0.01%
+69,941
New +$367K
VWOB icon
1266
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
$274K ﹤0.01%
3,528
-52
-1% -$4.04K
GNOM icon
1267
Global X Genomics & Biotechnology ETF
GNOM
$81.1M
$273K ﹤0.01%
3,444
-5,296
-61% -$445K
GNW icon
1268
Genworth Financial
GNW
$3.81B
$273K ﹤0.01%
67,500
HUSV icon
1269
First Trust Horizon Managed Volatility Domestic ETF
HUSV
$76M
$273K ﹤0.01%
7,611
-207
-3% -$7.01K
PTY icon
1270
PIMCO Corporate & Income Opportunity Fund
PTY
$2.49B
$273K ﹤0.01%
16,480
+6,438
+64% +$115K
SBRA icon
1271
Sabra Healthcare REIT
SBRA
$5.38B
$273K ﹤0.01%
+20,181
New +$286K
WIA
1272
Western Asset Inflation-Linked Income Fund
WIA
$185M
$273K ﹤0.01%
20,600
AOS icon
1273
A.O. Smith
AOS
$8.24B
$272K ﹤0.01%
3,167
-67,749
-96% -$5.16M
DBO icon
1274
Invesco DB Oil Fund
DBO
$396M
$272K ﹤0.01%
20,039
+734
+4% +$10.3K
GPRO icon
1275
GoPro
GPRO
$124M
$272K ﹤0.01%
+26,360
New +$261K

Similar funds

Oppenheimer & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Oppenheimer & Co held 1,615 positions worth $5.72B, up 7.1% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q4 2021 filing shows 130 new, 604 increased, 665 reduced and 130 closed positions. Its largest new stake was Invesco Total Return Bond ETF: 132,838 shares worth $7.49M. The largest sale was Global X S&P 500 Covered Call ETF, an estimated $49.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q4 2021 buy was Invesco Total Return Bond ETF: 132,838 shares worth $7.49M.
  • Oppenheimer & Co added most to Canadian Pacific Kansas City in Q4 2021, an estimated $7.48M increase.
  • Oppenheimer & Co's biggest Q4 2021 reduction was Global X S&P 500 Covered Call ETF, cutting an estimated $49.9M.
  • Oppenheimer & Co fully exited Kansas City Southern in Q4 2021, selling an estimated $6.61M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.72B portfolio in Q4 2021.
  • Oppenheimer & Co opened 130 new positions and closed 130 in Q4 2021.
  • Oppenheimer & Co's portfolio value rose 7.1% quarter-over-quarter to $5.72B.

Based on Oppenheimer & Co's 13F filing for Q4 2021, filed 2 Feb 2022.